1.
Chinese Journal of Practical Internal Medicine
;
(12): 412-415, 2019.
Article
in Chinese
| WPRIM
| ID: wpr-816035
ABSTRACT
Lung cancer comorbidity is common in patients. This review focuses on the clinical situations and treatment of patients with both lung cancer and one of the following: chronic obstructive pulmonary disease(COPD), pulmonary embolism(PE) or interstitial lung disease(ILD). Generally, these patients have more limitations on selecting cancer-related therapies, and they have shorter survival time and higher mortality than patients who had lung cancers only.